These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17139577)

  • 21. Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both.
    Taylor SR; Meadowcraft LM; Williamson B
    Pharmacotherapy; 2015 Aug; 35(8):780-92. PubMed ID: 26289308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome: diabetes and cardiovascular disease.
    Gupta S; Gupta BM
    Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Metabolic syndrome: epidemiology and its risks].
    Lameira D; Lejeune S; Mourad JJ
    Ann Dermatol Venereol; 2008 Feb; 135 Suppl 4():S249-53. PubMed ID: 18466792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The metabolic syndrome in South Asians: epidemiology, determinants, and prevention.
    Misra A; Khurana L
    Metab Syndr Relat Disord; 2009 Dec; 7(6):497-514. PubMed ID: 19900153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The metabolic syndrome: definition, pathogenesis and therapy.
    Demacker PN
    Eur J Clin Invest; 2007 Feb; 37(2):85-9. PubMed ID: 17217372
    [No Abstract]   [Full Text] [Related]  

  • 26. Management of metabolic syndrome and associated cardiovascular risk factors.
    De Flines J; Scheen AJ
    Acta Gastroenterol Belg; 2010; 73(2):261-6. PubMed ID: 20690566
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [IDEFICS: a multicenter European project on diet- and lifestyle-related disorders in children].
    Bammann K; Peplies J; Pigeot I; Ahrens W
    Med Klin (Munich); 2007 Mar; 102(3):230-5. PubMed ID: 17345019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal treatments for the metabolic syndrome.
    Giugliano D; Esposito K
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):e30. PubMed ID: 16556857
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic syndrome defined by modified International Diabetes Federation criteria and type 2 diabetes mellitus risk: a 9-year follow-up among the aged in Finland.
    Salminen M; Kuoppamäki M; Vahlberg T; Räihä I; Irjala K; Kivelä SL
    Diab Vasc Dis Res; 2013 Jan; 10(1):11-6. PubMed ID: 22461662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity and Metabolic Syndrome Among Adult Survivors of Childhood Leukemia.
    Gibson TM; Ehrhardt MJ; Ness KK
    Curr Treat Options Oncol; 2016 Apr; 17(4):17. PubMed ID: 26951206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic syndrome: from global epidemiology to individualized medicine.
    Batsis JA; Nieto-Martinez RE; Lopez-Jimenez F
    Clin Pharmacol Ther; 2007 Nov; 82(5):509-24. PubMed ID: 17851562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of the metabolic syndrome in a Turkish adult population.
    Ozsahin AK; Gokcel A; Sezgin N; Akbaba M; Guvener N; Ozisik L; Karademir BM
    Diabetes Nutr Metab; 2004 Aug; 17(4):230-4. PubMed ID: 15575344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Non-alcoholic fatty liver disease (NAFLD) in patients with metabolic syndrome and type 2 diabetes mellitus. Pathomechanism, new diagnostic markers].
    Kieć-Wilk B; Klupa T; Dembińska-Kieć A
    Przegl Lek; 2010; 67(7):496-501. PubMed ID: 21387764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metabolically obese normal-weight individuals and metabolically healthy, but obese, subjects].
    Beck E; Esser N; Paquot N; Scheen AJ
    Rev Med Suisse; 2009 Aug; 5(214):1644-6, 1648-9. PubMed ID: 19772195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is the fructose index more relevant with regards to cardiovascular disease than the glycemic index?
    Segal MS; Gollub E; Johnson RJ
    Eur J Nutr; 2007 Oct; 46(7):406-17. PubMed ID: 17763967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hormonal contraception in obesity, the metabolic syndrome, and diabetes.
    Skouby SO
    Ann N Y Acad Sci; 2010 Sep; 1205():240-4. PubMed ID: 20840279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome in young people.
    Poyrazoglu S; Bas F; Darendeliler F
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):56-63. PubMed ID: 24247648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomised controlled trial of a physical activity and nutrition program targeting middle-aged adults at risk of metabolic syndrome in a disadvantaged rural community.
    Blackford K; Jancey J; Lee AH; James AP; Howat P; Hills AP; Anderson A
    BMC Public Health; 2015 Mar; 15():284. PubMed ID: 25885657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of lipid disorders in metabolic syndrome and type 2 diabetes. The place for fibrates].
    Cybulska B; Kłosiewicz-Latoszek L
    Kardiol Pol; 2005 Jun; 62 Suppl 2():II45-50. PubMed ID: 19813336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.